focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.10
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.30 (27.273%)
Open: 1.25
High: 1.25
Low: 1.25
Prev. Close: 1.25
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Physiomics wins deal; DeepVerge eyes cash raise

Wed, 12th Oct 2022 11:18

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Physiomics PLC, up 27% at 2.68 pence, 12-month range 2.00p-7.25p. The oncology consultant wins an agreement to work with Cancer Research UK. It will use its modelling capabilities to support the Cancer Research-sponsored early phase clinical development of ALETA-001, a candidate for the treatment of blood cancers developed by Aleta Biotherapeutics.

----------

Invinity Energy Systems PLC, up 6.3% at 26.05 pence, 12-month range 0.20p-26.62p. The utility-grade energy storage manufacturer sells a battery system to Equans Belux, a Belgian multi-technical installations and maintenance services provider. The sale represents Invinity's maiden foray into the European market.

----------

AIM - LOSERS

----------

DeepVerge PLC, down 40% at 3.35p, 12-month range 3.22p-33.00p. The Dublin-based environmental and life science group says there can be no guarantee it raises "sufficient equity funds", due to its low share price, as repayments for a loan fall due. It secured a GBP25 million loan in March, of which an initial GBP4 million was drawn. Monthly repayments begin on Monday, with an initial GBP500,000 due. DeepVerge says there will be no default on the loan despite any missed payments up to November 14, assuming principal and interest payments are made following a proposed equity raise. "In parallel with seeking to strengthen the balance sheet, the company is in the process of strengthening and reorganising the board to reflect the recent fast pace of growth and that expected in 2023 and beyond," it adds.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
14 May 2021 10:23

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

Read more
14 May 2021 09:27

Physiomics secures follow-on contract from Merck KgaA

Physiomics secures follow-on contract from Merck KgaA

Read more
14 May 2021 08:27

Physiomics secures additional contract with Merck

(Sharecast News) - Drug development consultancy Physiomics has been awarded a further contract with a leading science and technology company Merck.

Read more
11 May 2021 17:50

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Read more
11 May 2021 10:46

Physiomics secures contract with Numab Therapeutics

(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.

Read more
10 May 2021 10:21

Physiomics says full-year results to disappoint market forecasts

Physiomics says full-year results to disappoint market forecasts

Read more
10 May 2021 10:19

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

Read more
10 May 2021 08:40

Physiomics FY income likely to fall short of market expectations

(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19 related project delays and an increased focus on longer-term value-generating activities.

Read more
1 Mar 2021 11:29

AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes

AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes

Read more
1 Mar 2021 11:22

TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit

TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit

Read more
15 Feb 2021 16:04

Physiomics and ValiRx enter new collaboration deal

(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the two companies, which was announced in September 2011.

Read more
15 Feb 2021 11:05

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

Read more
17 Dec 2020 15:52

UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand

UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand

Read more
17 Dec 2020 13:59

Physiomics gets initial 2021 commitment from client Merck

(Sharecast News) - Oncology consultancy Physiomics announced on Thursday that its existing client, Merck, has committed to an initial tranche of projects for 2021 with a total value of £0.27m.

Read more
14 Dec 2020 19:35

UK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares

UK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.